Skip to main content
    Health Library

    Weight management · 4 min read · Evidence-informed guide

    Who May Qualify for GLP-1 Weight-Loss Medicine?

    Eligibility for a prescription weight-management medicine is not decided by interest alone. FDA-approved products have specific indications, and a clinician must assess weight-related health conditions, medical history, contraindications, current medicines, pregnancy plans, and whether the expected benefit outweighs risk.

    Key answer

    The short version

    Eligibility for a prescription weight-management medicine is not decided by interest alone. FDA-approved products have specific indications, and a clinician must assess weight-related health conditions, medical history, contraindications, current medicines, pregnancy plans, and whether the expected benefit outweighs risk.

    FDA indications are a starting point

    For example, Wegovy is indicated for chronic weight management in adults with obesity or in adults with overweight plus at least one weight-related condition, together with a reduced-calorie diet and increased physical activity. Product labels define the exact criteria.

    Safety screening matters

    Screening can include prior pancreatitis, gallbladder disease, severe gastrointestinal symptoms, diabetes medicines, personal or family history relevant to label contraindications, and reproductive plans.

    A prescription is one part of care

    A thoughtful program includes nutrition, activity, sleep, medical follow-up, side-effect management, and a plan for access and continuity—not simply an online prescription.

    Clinical perspective

    How to think about this

    Prescription weight management is longitudinal medical care, not a consumer transaction. A sound plan weighs approved use, safety, nutrition, access, follow-up, and the patient’s own goals; it should never reduce a complex health decision to a promised outcome or a single number on a scale.

    Questions worth bringing to a visit

    • What FDA-approved option, if any, fits my clinical situation?
    • What safety monitoring and follow-up would I need?
    • How will we assess benefit, tolerability, and access over time?

    Continue exploring

    Sources

    1. 1. FDA, Wegovy Prescribing Information

      FDA-approved indications, contraindications, and safety information.

    2. 2. NIDDK, Prescription Medications to Treat Overweight & Obesity

      NIH overview of eligibility and medication as part of care.